Biomaterials Market - A Global and Regional Analysis: Focus on Applications, Product Types, and Countries - Analysis and Forecast, 2021-2031

Table of Contents

1 Markets
1.1 Industry Outlook
1.1.1 Trends: Current and Future
1.1.2 Supply Chain Network
1.1.3 Industry Attractiveness
1.1.3.1 Threat of New Entrants (Moderate)
1.1.3.2 Bargaining Power of Buyers (Moderate)
1.1.3.3 Bargaining Power of Suppliers (Moderate)
1.1.3.4 Threat of Substitutes (Low)
1.1.3.5 Intensity of Competitive Rivalry (High)
1.1.4 Patent Analysis
1.1.4.1 Patent Analysis (by Status)
1.1.4.2 Patent Analysis (by Organization)
1.2 Market Dynamics
1.2.1 Market Driver
1.2.1.1 Increasing Funds/Aids by Government for Research Purposes
1.2.1.2 Increasing Plastic Surgery and Wound Healing Therapies
1.2.1.3 Increasing Aging/Geriatric Population
1.2.1.4 Rise in Prevalence of Cardiovascular Diseases
1.2.1.5 Increasing Orthopedic Disorders
1.2.1.6 Growing Demand for Implantable Devices
1.2.1.7 Increasing Awareness of Regenerative Medicine
1.2.2 Market Restraint
1.2.2.1 Biocompatibility Issues and Safety and Stringent Regulations
1.2.2.2 Limitations of Biomaterial-Based Products
1.2.3 Market Opportunity
1.2.3.1 Increasing Obesity
1.2.3.2 Patient Awareness and Improved Lifestyle in Emerging Economies
1.2.3.3 Introduction of Biomaterials in Cancer Research
1.2.4 Business and Corporate Strategies
1.2.4.1 Key Market Development and Strategies
1.2.4.2 Product Launches and Developments
1.2.4.3 Partnerships, Collaborations, and Contracts
1.2.4.4 Business Expansions
1.2.4.5 Mergers, Acquisitions, and Joint Ventures
1.2.4.6 Other Key Developments

2 Application
2.1 Global Biomaterials Market (by Application, Sub-Application and Specification)
2.2 Demand Analysis of Global Biomaterials Market (by Application and Sub-Application), Value and Volume Data
2.2.1 Cardiovascular
2.2.1.1 Catheters
2.2.1.2 Stents
2.2.1.3 Heart Valves
2.2.1.4 Guidewires
2.2.1.5 Sensors
2.2.1.6 Pacemaker
2.2.1.7 Implantable Cardiac Defibrillators (ICD)
2.2.1.8 Vascular Grafts
2.2.2 Orthopedic
2.2.2.1 Joint Replacement
2.2.2.1.1 Hip Replacement
2.2.2.1.2 Knee Replacement
2.2.2.1.3 Shoulder Replacement
2.2.2.1.4 Other Replacement
2.2.2.2 Viscos Supplementation
2.2.2.3 Bioresorbable Tissue Fixation
2.2.2.3.1 Suture Anchors
2.2.2.3.2 Interference Screws
2.2.2.3.3 Meshes
2.2.2.4 Spine
2.2.2.4.1 Minimally Invasive Fusion Surgeries
2.2.2.4.2 Motion Preservation and Dynamic Stabilization
2.2.2.4.2.1 Pedicle-Based-Rod Systems
2.2.2.4.2.2 Interspinous Spacers
2.2.2.4.2.3 Disc Arthroplasty/Replacement
2.2.2.5 Fracture Fixation
2.2.2.5.1 Bone Plates
2.2.2.5.2 Screws
2.2.2.5.3 Pins
2.2.2.5.4 Rods
2.2.2.6 Fracture Fixation
2.2.2.6.1 Bone Grafts
2.2.3 Ophthalmology
2.2.3.1 Contact Lenses
2.2.3.2 Intraocular Lenses
2.2.3.3 Functional Replacement of Ocular Tissues
2.2.3.4 Synthetic Corneas
2.2.3.5 Others
2.2.4 Dental
2.2.4.1 Dental Bone Grafts and Substitutes
2.2.4.2 Dental Membranes
2.2.5 Wound Healing
2.2.5.1 Wound Closure Devices
2.2.5.2 Sutures
2.2.5.3 Staples
2.2.5.4 Surgical Hemostats
2.2.5.5 Internatal Tissue Sealants
2.2.5.6 Adhesion Barriers
2.2.5.7 Hernia Meshes
2.2.6 Plastic Surgery
2.2.6.1 Soft Tissue Fillers
2.2.6.2 Craniofacial Surgery
2.2.7 Neurological/Central Nervous System
2.2.7.1 Shunting Systems
2.2.7.2 Cortical Neural Prosthetics (CNP)
2.2.7.3 Hydrogel Scaffolds for CNS Report
2.2.7.4 Neural Stem Cell Encapsulation
2.2.8 Tissue Engineering
2.2.8.1 Scaffolds for Regenerative Medicine
2.2.8.2 Nanomaterial for Biosensing
2.2.8.3 Tailoring of Inorganic Nanoparticles
2.2.9 Others
2.2.9.1 Drug Delivery Systems
2.2.9.2 Gastrointestinal Applications
2.2.9.3 Bariatric Surgery
2.2.9.4 Urinary Applications

3 Products
3.1 Global Biomaterials Market (by Product Type, Sub-Product Type and Specifications)
3.2 Demand Analysis of Global Biomaterials Market (by Product Type and Sub-Product Type), Value and Volume Data
3.2.1 Metal-Based Biomaterials
3.2.1.1 Stainless Steel
3.2.1.2 Titanium and Titanium alloys
3.2.1.3 Cobalt-Chromium (Co-Cr) Alloys
3.2.1.4 Magnesium (Mg)
3.2.1.5 Gold (Au)
3.2.1.6 Silver (Ag)
3.2.1.7 Nitinol
3.2.1.8 Other Metal-Based Biomaterials
3.2.2 Polymer-Based Biomaterials
3.2.2.1 Polyethylene Terephthalate (PET)
3.2.2.2 Polypropylene (PP)
3.2.2.3 Polyetheretherketone (PEEK)
3.2.2.4 Ultra-High Molecular Weight Polyethylene (UHMWPE)
3.2.2.5 Polytetrafluoroethylene (PTFE)
3.2.2.6 Polyglycolide (PGA)
3.2.2.7 Polyactide (PLA)
3.2.2.8 Polycaprolactone (PCL)
3.2.2.9 Polyglycerol Sebacate (PGS)
3.2.2.10 Polyvinylchloride (PVC)
3.2.2.11 Silicone Rubber
3.2.2.12 Nylon
3.2.2.13 Polymethyl Methacrylate (PMMA)
3.2.2.14 Other Polymer-Based Biomaterials
3.2.3 Ceramic-Based Biomaterials
3.2.3.1 Alumina
3.2.3.2 Calcium Phosphate
3.2.3.3 Zirconia
3.2.3.4 Calcium Sulfate
3.2.3.5 Carbon
3.2.3.6 Other Ceramic-Based Biomaterials
3.2.4 Natural-Based Biomaterials
3.2.4.1 Collagen
3.2.4.2 Fibrin
3.2.4.3 Gelatin
3.2.4.4 Silk
3.2.4.5 Alginates
3.2.4.6 Hyaluronic Acid
3.2.4.7 Chitin and Chitosan
3.2.4.8 Cellulose
3.2.5 Inorganic Glass-Based Biomaterials
3.2.5.1 Silicates
3.2.5.2 Bioactive Glass
3.2.5.3 Phosphate
3.2.6 Radiopaque Biomaterials
3.2.7 Regenerative Biomaterials
3.2.8 Hybrid Biomaterial Combinations

4 Region
4.1 North America
4.1.1 Market
4.1.1.1 Key Manufacturers and Suppliers in North America
4.1.1.2 Business Drivers
4.1.1.3 Business Challenges
4.1.2 Applications
4.1.2.1 North America Biomaterials Market (by Application and Sub-Application), Value and Volume Data
4.1.3 Product
4.1.3.1 North America Biomaterials Market (by Product Type and Sub-Product Type), Value and Volume Data
4.1.4 North America (by Country)
4.1.4.1 U.S.
4.1.4.1.1 Market
4.1.4.1.1.1 Buyer Attributes
4.1.4.1.1.2 Key Manufacturers and Suppliers in the U.S.
4.1.4.1.1.3 Business Challenges
4.1.4.1.1.4 Business Drivers
4.1.4.1.2 Application
4.1.4.1.2.1 U.S. Biomaterials Market (by Application and Sub-Application)
4.1.4.1.3 Product
4.1.4.1.3.1 U.S. Biomaterials Market (by Product Type and Sub-Product Type)
4.1.4.2 Canada
4.1.4.2.1 Market
4.1.4.2.1.1 Buyer Attributes
4.1.4.2.1.2 Key Manufacturers and Suppliers in Canada
4.1.4.2.1.3 Business Challenges
4.1.4.2.1.4 Business Drivers
4.1.4.2.2 Application
4.1.4.2.2.1 Canada Biomaterials Market (by Application and Sub-Application)
4.1.4.2.3 Product
4.1.4.2.3.1 Canada Biomaterials Market (by Product Type and Sub-Product Type)
4.1.4.3 Mexico
4.1.4.3.1.1 Buyer Attributes
4.1.4.3.1.2 Key Manufacturers and Suppliers in Mexico
4.1.4.3.1.3 Business Challenges
4.1.4.3.1.4 Business Drivers
4.1.4.3.2 Application
4.1.4.3.2.1 Mexico Biomaterials Market (by Application and Sub-Application)
4.1.4.3.3 Product
4.1.4.3.3.1 Mexico Biomaterials Market (by Product Type and Sub-Product Type)
4.2 Europe
4.2.1 Market
4.2.1.1 Key Manufacturers and Suppliers in Europe
4.2.1.2 Business Drivers
4.2.1.3 Business Challenges
4.2.2 Applications
4.2.2.1 Europe Biomaterials Market (by Application and Sub-Application), Value and Volume Data
4.2.3 Product
4.2.3.1 Europe Biomaterials Market (by Product Type and Sub-Product Type), Value and Volume Data
4.2.4 Europe (by Country)
4.2.4.1 Germany
4.2.4.1.1 Market
4.2.4.1.1.1 Buyer Attributes
4.2.4.1.2 Key Manufacturers and Suppliers in Germany
4.2.4.1.3 Business Challenges
4.2.4.1.4 Business Drivers
4.2.4.1.5 Application
4.2.4.1.5.1 Germany Biomaterials Market (by Application and Sub-Application)
4.2.4.1.6 Product
4.2.4.1.6.1 Germany Biomaterials Market (by Product Type and Sub-Product Type)
4.2.4.2 France
4.2.4.2.1 Market
4.2.4.2.1.1 Buyer Attributes
4.2.4.2.1.2 Key Manufacturers and Suppliers in France
4.2.4.2.1.3 Business Challenges
4.2.4.2.1.4 Business Drivers
4.2.4.2.2 Application
4.2.4.2.2.1 France Biomaterials Market (by Application and Sub-application)
4.2.4.2.3 Product
4.2.4.2.3.1 France Biomaterials Market (by Product Type and Sub-Product Type)
4.2.4.3 Spain
4.2.4.3.1 Market
4.2.4.3.1.1 Buyer Attributes
4.2.4.3.1.2 Key Manufacturers and Suppliers in Spain
4.2.4.3.1.3 Business Challenges
4.2.4.3.1.4 Business Drivers
4.2.4.3.2 Application
4.2.4.3.2.1 Spain Biomaterials Market (by Application and Sub-Application)
4.2.4.3.3 Product
4.2.4.3.3.1 Spain Biomaterials Market (by Product Type and Sub-Product Type)
4.2.4.4 Italy
4.2.4.4.1 Market
4.2.4.4.1.1 Buyer Attributes
4.2.4.4.1.2 Key Manufacturers and Suppliers in Italy
4.2.4.4.1.3 Business Challenges
4.2.4.4.1.4 Business Drivers
4.2.4.4.2 Application
4.2.4.4.2.1 Italy Biomaterials Market (by Application and Sub-Application)
4.2.4.4.3 Product
4.2.4.4.3.1 Italy Biomaterials Market (by Product Type and Sub-Product Type)
4.2.4.5 Russia
4.2.4.5.1 Market
4.2.4.5.1.1 Buyer Attributes
4.2.4.5.1.2 Key Manufacturers and Suppliers in Russia
4.2.4.5.1.3 Business Challenges
4.2.4.5.1.4 Business Drivers
4.2.4.5.2 Application
4.2.4.5.2.1 Russia Biomaterials Market (by Application and Sub-Application)
4.2.4.5.3 Product
4.2.4.5.3.1 Russia Biomaterials Market (by Product Type and Sub-Product Type)
4.2.4.6 Rest-of-Europe
4.2.4.6.1 Application
4.2.4.6.1.1 Rest-of-Europe Biomaterials Market (by Application and Sub-Application)
4.2.4.6.2 Product
4.2.4.6.2.1 Rest-of-Europe Biomaterials Market (by Product Type and Sub-Product Type)
4.3 U.K.
4.3.1 Market
4.3.1.1 Buyer Attributes
4.3.1.2 Key Manufacturers and Suppliers in the U.K.
4.3.1.3 Business Challenges
4.3.1.4 Business Drivers
4.3.2 Applications
4.3.2.1 U.K. Biomaterials Market (by Application and Sub-Application)
4.3.3 Product
4.3.3.1 U.K. Biomaterials Market (by Product Type and Sub-Product Type)
4.4 China
4.4.1 Market
4.4.1.1 Buyer Attributes
4.4.1.2 Key Manufacturers and Suppliers in China
4.4.1.3 Business Challenges
4.4.1.4 Business Drivers
4.4.2 Applications
4.4.2.1 China Biomaterials Market (by Application and Sub-Application)
4.4.3 Product
4.4.3.1 China Biomaterials Market (by Product Type and Sub-Product Type)
4.5 Asia-Pacific and Japan
4.5.1 Market
4.5.1.1 Key Manufacturers and Suppliers in Asia-Pacific and Japan
4.5.1.2 Business Drivers
4.5.1.3 Business Challenges
4.5.2 Applications
4.5.2.1 Asia-Pacific & Japan Biomaterials Market (by Application and Sub-Application), Value and Volume Data
4.5.3 Product
4.5.3.1 Asia-Pacific & Japan Biomaterials Market (by Product Type and Sub-Product Type), Value and Volume Data
4.5.4 Asia-Pacific (by Country)
4.5.4.1 Japan
4.5.5 Market
4.5.5.1 Buyer Attributes
4.5.5.2 Key Manufacturers and Suppliers in Japan
4.5.5.3 Business Challenges
4.5.5.4 Business Drivers
4.5.5.4.1 Application
4.5.5.4.1.1 Japan Biomaterials Market (by Application and Sub-Application)
4.5.5.4.2 Product
4.5.5.4.2.1 Japan Biomaterials Market (by Product Type and Sub-Product Type)
4.5.5.2 South Korea
4.5.6 Market
4.5.6.1 Buyer Attributes
4.5.6.2 Key Manufacturers and Suppliers in South Korea
4.5.6.3 Business Challenges
4.5.6.4 Business Drivers
4.5.6.4.1 Application
4.5.6.4.1.1 South Korea Biomaterials Market (by Application and Sub-Application)
4.5.6.4.2 Product
4.5.6.4.2.1 South Korea Biomaterials Market (by Product Type and Sub-Product Type)
4.5.6.5 India
4.5.7 Market
4.5.7.1 Buyer Attributes
4.5.7.2 Key Manufacturers and Suppliers in India
4.5.7.3 Business Challenges
4.5.7.4 Business Drivers
4.5.7.4.1 Application
4.5.7.4.1.1 India Biomaterials Market (by Application and Sub-Application)
4.5.7.4.2 Product
4.5.7.4.2.1 India Biomaterials Market (by Product Type and Sub-Product Type)
4.5.7.5 Rest-of-Asia-Pacific
4.5.7.5.1 Application
4.5.7.5.1.1 Rest-of-Asia-Pacific Biomaterials Market (by Application and Sub-Application)
4.5.7.5.2 Product
4.5.7.5.2.1 Rest-of-Asia-Pacific Biomaterials Market (by Product Type and Sub-Product Type)
4.6 Rest-of-the-World
4.6.1 Market
4.6.1.1 Key Manufacturers and Suppliers in Rest-of-the-World
4.6.1.2 Business Drivers
4.6.1.3 Business Challenges
4.6.2 Applications
4.6.2.1 Rest-of-the-World Biomaterials Market (by Application and Sub-Application), Value and Volume Data
4.6.3 Product
4.6.3.1 Rest-of-the-World Biomaterials Market (by Product Type and Sub-Product Type), Value and Volume Data
4.6.3.2 South America
4.6.4 Market
4.6.4.1 Buyer Attributes
4.6.4.2 Key Manufacturers and Suppliers in South America
4.6.4.3 Business Challenges
4.6.4.4 Business Drivers
4.6.4.4.1 Application
4.6.4.4.1.1 South America Biomaterials Market (by Application and Sub-Application)
4.6.4.4.2 Product
4.6.4.4.2.1 South America Biomaterials Market (by Product Type and Sub-Product Type)
4.6.4.5 Middle East and Africa
4.6.5 Market
4.6.5.1 Buyer Attributes
4.6.5.2 Key Manufacturers and Suppliers in Middle East and Africa
4.6.5.3 Business Challenges
4.6.5.4 Business Drivers
4.6.5.4.1 Application
4.6.5.4.1.1 Middle East and Africa Biomaterials Market (by Application and Sub-Application)
4.6.5.4.2 Product
4.6.5.4.2.1 Middle East and Africa Biomaterials Market (by Product Type and Sub-Product Type)

5 Markets - Competitive Benchmarking & Company Profiles
5.1 Competitive Benchmarking
5.2 Company Profiles
5.2.1 BASF SE
5.2.1.1 Company Overview
5.2.1.2 Product Portfolio
5.2.1.3 Corporate Strategies
5.2.1.4 Production Sites and R&D Analysis
5.2.1.5 Strengths of the Company in the Global Biomaterials Market
5.2.1.6 Weakness of the Company in the Global Biomaterials Market
5.2.2 Carpenter Technology Corporation
5.2.2.1 Company Overview
5.2.2.2 Product Portfolio
5.2.2.3 Corporate Strategies
5.2.2.4 Production Sites and R&D Analysis
5.2.2.5 Strengths of the Company in the Global Biomaterials Market
5.2.2.6 Weaknesses of the Company in the Global Biomaterials Market
5.2.3 Celanese Corporation
5.2.3.1 Company Overview
5.2.3.2 Product Portfolio
5.2.3.3 Corporate Strategies
5.2.3.4 Production Sites and R&D Analysis
5.2.3.5 Strengths of the Company in the Global Biomaterials Market
5.2.3.6 Weaknesses of the Company in the Global Biomaterials Market
5.2.4 Collagen Solutions Plc
5.2.4.1 Company Overview
5.2.4.2 Product Portfolio
5.2.4.3 Corporate Strategies
5.2.4.4 Strengths of the Company in the Global Biomaterials Market
5.2.4.5 Weakness of the Company in the Global Biomaterials Market
5.2.5 Corbion N.V.
5.2.5.1 Company Overview
5.2.5.2 Product Portfolio
5.2.5.3 Corporate Strategies
5.2.5.4 Production Sites and R&D Analysis
5.2.5.5 Strengths of the Company in the Global Biomaterials Market
5.2.5.6 Weaknesses of the Company in the Global Biomaterials Market
5.2.6 Covestro AG
5.2.6.1 Company Overview
5.2.6.2 Product Portfolio
5.2.6.3 Corporate Strategies
5.2.6.4 Production Sites and R&D Analysis
5.2.6.5 Strengths of the Company in the Global Biomaterials Market
5.2.6.6 Weaknesses of the Company in the Global Biomaterials Market
5.2.7 DSM
5.2.7.1 Company Overview
5.2.7.2 Product Portfolio
5.2.7.3 Corporate Strategies
5.2.7.4 Production Sites and R&D Analysis
5.2.7.5 Strengths of the Company in the Global Biomaterials Market
5.2.7.6 Weaknesses of the Company in the Global Biomaterials Market
5.2.8 Evonik Industries
5.2.8.1 Company Overview
5.2.8.2 Product Portfolio
5.2.8.3 Corporate Strategies
5.2.8.4 Production Sites and R&D Analysis
5.2.8.5 Strengths of the Company in the Global Biomaterials Market
5.2.8.6 Weakness of the Company in the Global Biomaterials Market
5.2.9 Zimmer Biomet
5.2.9.1 Company Overview
5.2.9.2 Product Portfolio
5.2.9.3 Corporate Strategies
5.2.9.4 Production Sites and R&D Analysis
5.2.9.5 Strengths of the Company in the Global Biomaterials Market
5.2.9.6 Weaknesses of the Company in the Global Biomaterials Market
5.2.10 Wright Medical Group N.V.
5.2.10.1 Company Overview
5.2.10.2 Product Portfolio
5.2.10.3 Corporate Strategies
5.2.10.4 Strength of the Company in the Global Biomaterials Market
5.2.10.5 Weakness of the Company in the Global Biomaterials Market
5.2.11 Mitsubishi Chemical Holdings Corporation.
5.2.11.1 Company Overview
5.2.11.2 Product Portfolio
5.2.11.3 Corporate Strategies
5.2.11.4 Production Sites and R&D Analysis
5.2.11.5 Strengths of the Company in the Global Biomaterials Market
5.2.11.6 Weaknesses of the Company in the Global Biomaterials Market
5.2.12 Riton Biomaterial Co., Ltd.
5.2.12.1 Company Overview
5.2.12.2 Product Portfolio
5.2.12.3 Strength of the Company in the Global Biomaterials Market
5.2.12.4 Weakness of the Company in the Global Biomaterials Market
5.2.13 Berkeley Advanced Biomaterials Inc.
5.2.13.1 Company Overview
5.2.13.2 Product Portfolio
5.2.13.3 Strength of the Company in the Global Biomaterials Market
5.2.13.4 Weakness of the Company in the Global Biomaterials Market
5.2.14 BBS-Bioactive Bone Substitutes Oyj
5.2.14.1 Company Overview
5.2.14.2 Product Portfolio
5.2.14.3 Corporate Strategies
5.2.14.4 Strength of the Company in the Global Biomaterials Market
5.2.14.5 Weakness of the Company in the Global Biomaterials Market
5.2.15 Bioretec Ltd.
5.2.15.1 Company Overview
5.2.15.2 Product Portfolio
5.2.15.3 Corporate Strategies
5.2.15.4 Strength of the Company in the Global Biomaterials Market
5.2.15.5 Weakness of the Company in the Global Biomaterials Market

6 Research Methodology

List of Figures
Figure 1: Global Biomaterials Market Snapshot, 2020, 2021 and 2031
Figure 2: Global Biomaterials Market (by Product Type)
Figure 3: Global Biomaterials Market (by Region), $Billion, 2021 and 2031
Figure 4: Global Biomaterials Market: Coverage
Figure 5: Supply Chain Analysis of Global Biomaterials Market
Figure 6: Porter’s Five Forces Analysis
Figure 7: Year-Wise Patents Filed in Global Biomaterials Market, January 2018-August 2021
Figure 8: Patent Analysis (by Status), January 2018-August 2021
Figure 9: Patent Analysis (by Organization), January 2018-August 2021
Figure 10: Market Dynamics: Global Biomaterials Market
Figure 11: Number of Plastic Surgery Procedures (by Country), 2019
Figure 12: Leading Causes of Deaths by American Heart Association
Figure 13: Total Developments of Biomaterials (2018-2021)
Figure 14: Competitive Benchmarking Matrix
Figure 15: R&D Expenditure of BASF SE, 2019-2020
Figure 16: R&D Expenditure of Carpenter Technology Corporation, 2018-2020
Figure 17: R&D Expenditure of Celanese Corporation, 2018-2020
Figure 18: R&D Expenditure of Corbion N.V., 2019-2020
Figure 19: R&D Expenditure of Covestro AG, 2019-2020
Figure 20: R&D Expenditure of DSM, 2019-2020
Figure 21: R&D Expenditure of Evonik Industries, 2018-2020
Figure 22: R&D Expenditure of Zimmer Biomet, 2019-2020
Figure 23: R&D Expenditure of Mitsubishi Chemical Holdings Corporation, 2019-2020
Figure 24: Research Methodology
Figure 25: Top-Down and Bottom-Up Approach
Figure 26: Assumptions and Limitations

List of Tables
Table 1: Global Biomaterials Market (by Application)
Table 2: Key Factor in Determining “Threat of New Entrants” in Biomaterials Market
Table 3: Key Factor in Determining “Bargaining Power of Buyers” in Biomaterials Market
Table 4: Key Factor in Determining “Bargaining Power of Suppliers” in Biomaterials Market
Table 5: Key Factor in Determining “Threat of Substitutes” in Biomaterials Market
Table 6: Key Factor in Determining “Intensity of Competitive Rivalry” in Biomaterials Market
Table 7: Impact Analysis of Driver
Table 8: Global Aging Population
Table 9: Impact Analysis of Restraint
Table 10: Impact Analysis of Opportunity
Table 11: Key Product Launch and Development Activities (2018-2021)
Table 12: Key Partnerships, Collaborations, and Contracts (2018-2021)
Table 13: Key Business Expansion Activities (2018-2021)
Table 14: Key Mergers, Acquisitions, and Joint Ventures (2018-2021)
Table 15: Other Key Developments (2018-2021)
Table 16: Global Biomaterials Market (by Application and Sub-Application), $Billion, 2020-2031
Table 17: Global Biomaterials Market (by Application), Kilo Ton, 2020 -2031
Table 18: Global Biomaterials Market (by Product Type and Sub-Product Type), $Billion, 2020-2031
Table 19: Global Biomaterials Market (by Product Type), Kilo Ton, 2020-2031
Table 20: North America Biomaterials Market (by Application and Sub-Application), $Billion, 2020-2031
Table 21: North America Biomaterials Market (by Application), Kilo Ton, 2020-2031
Table 22: North America Biomaterials Market (by Product Type and Sub-Product Type), $Billion, 2020-2031
Table 23: North America Biomaterials Market (by Product Type), Kilo Ton, 2020-2031
Table 24: U.S. Biomaterials Market (by Application and Sub-Application), $Billion, 2020-2031
Table 25: U.S. Biomaterials Market (by Product Type and Sub-Product Type), $Billion, 2020-2031
Table 26: Canada Biomaterials Market (by Application and Sub-Application), $Billion, 2020-2031
Table 27: Canada Biomaterials Market (by Product Type and Sub-Product Type), $Billion, 2020-2031
Table 28: Mexico Biomaterials Market (by Application and Sub-Application), $Billion, 2020-2031
Table 29: Mexico Biomaterials Market (by Product Type and Sub-Product Type), $Billion, 2020-2031
Table 30: Europe Biomaterials Market (by Application and Sub-Application), $Billion, 2020-2031
Table 31: Europe Biomaterials Market (by Application), Kilo Ton, 2020-2031
Table 32: Europe Biomaterials Market (by Product Type and Sub-Product Type), $Billion, 2020-2031
Table 33: Europe Biomaterials Market (by Product Type), Kilo Ton, 2020-2031
Table 34: Germany Biomaterials Market (by Application and Sub-Application), $Billion, 2020-2031
Table 35: Germany Biomaterials Market (by Product Type and Sub-Product Type), $Billion, 2020-2031
Table 36: France Biomaterials Market (by Application and Sub-application), $Billion, 2020-2031
Table 37: France Biomaterials Market (by Product Type and Sub-Product Type), $Billion, 2020-2031
Table 38: Spain Biomaterials Market (by Application and Sub-Application), $Billion, 2020-2031
Table 39: Spain Biomaterials Market (by Product Type and Sub-Product Type), $Billion, 2020-2031
Table 40: Italy Biomaterials Market (by Application and Sub-Application), $Billion, 2020-2031
Table 41: Italy Biomaterials Market (by Product Type and Sub-Product Type), $Billion, 2020-2031
Table 42: Russia Biomaterials Market (by Application and Sub-Application), $Billion, 2020-2031
Table 43: Russia Biomaterials Market (by Product Type and Sub-Product Type), $Billion, 2020-2031
Table 44: Rest-of-Europe Biomaterials Market (by Application and Sub-Application), $Billion, 2020-2031
Table 45: Rest-of-Europe Biomaterials Market (by Product Type and Sub-Product Type), $Billion, 2020-2031
Table 46: U.K. Biomaterials Market (by Application and Sub-Application), $Billion, 2020-2031
Table 47: U.K. Biomaterials Market (by Product Type and Sub-Product Type), $Billion, 2020-2031
Table 48: China Biomaterials Market (by Application and Sub-Application), $Billion, 2020-2031
Table 49: China Biomaterials Market (by Product Type and Sub-Product Type), $Billion, 2020-2031
Table 50: Asia-Pacific & Japan Biomaterials Market (by Application and Sub-Application), $Billion, 2020-2031
Table 51: Asia-Pacific & Japan Biomaterials Market (by Application), Kilo Ton, 2020-2031
Table 52: Asia-Pacific & Japan Biomaterials Market (by Product Type and Sub-Product Type), $Billion, 2020-2031
Table 53: Asia-Pacific & Japan Biomaterials Market (by Product Type), Kilo Ton, 2020-2031
Table 54: Japan Biomaterials Market (by Application and Sub-Application), $Billion, 2020-2031
Table 55: Japan Biomaterials Market (by Product Type and Sub-Product Type), $Billion, 2020-2031
Table 56: South Korea Biomaterials Market (by Application and Sub-Application), $Billion, 2020-2031
Table 57: South Korea Biomaterials Market (by Product Type and Sub-Product Type), $Billion, 2020-2031
Table 58: India Biomaterials Market (by Application and Sub-Application), $Billion, 2020-2031
Table 59: India Biomaterials Market (by Product Type and Sub-Product Type), $Billion, 2020-2031
Table 60: Rest-of-Asia-Pacific Biomaterials Market (by Application and Sub-Application), $Billion, 2020-2031
Table 61: Rest-of-Asia-Pacific Biomaterials Market (by Product Type and Sub-Product Type), $Billion, 2020-2031
Table 62: Rest-of-the-World Biomaterials Market (by Application and Sub-Application), $Billion, 2020-2031
Table 63: Rest-of-the-World Biomaterials Market (by Application), Kilo Ton, 2020-2031
Table 64: Rest-of-the-World Biomaterials Market (by Product Type and Sub-Product Type), $Billion, 2020-2031
Table 65: Rest-of-the-World Biomaterials Market (by Product Type), Kilo Ton, 2020-2031
Table 66: South America Biomaterials Market (by Application and Sub-Application), $Billion, 2020-2031
Table 67: South America Biomaterials Market (by Product Type and Sub-Product Type), $Billion, 2020-2031
Table 68: Middle East and Africa Biomaterials Market (by Application and Sub-Application), $Billion, 2020-2031
Table 69: Middle East and Africa Biomaterials Market (by Product Type and Sub-Product Type), $Billion, 2020-2031

Companies Mentioned

• BASF SE
• Carpenter Technology Corporation
• Celanese Corporation
• Collagen Solutions Plc
• Corbion N.V.
• Covestro AG
• DSM
• Evonik Industries
• Zimmer Biomet
• Wright Medical Group N.V.
• Mitsubishi Chemical Holdings Corporation
• Riton Biomaterial Co., Ltd.
• Berkeley Advanced Biomaterials Inc.
• BBS-Bioactive Bone Substitutes Oyj
• Bioretec Ltd.